Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.
Nishikawa T, Inoue T, Otsuka T, Kuno I, Kukita Y, Nakamura H, Ikeda Y, Yasui T, Shioyama W, Oka T, Honma K, Hatakeyama K, Miyata H, Isei T, Ishihara R, Kumagai T, Nishimura K, Fujita M.
Nishikawa T, et al.
PLoS One. 2022 Nov 15;17(11):e0275865. doi: 10.1371/journal.pone.0275865. eCollection 2022.
PLoS One. 2022.
PMID: 36378654
Free PMC article.